DK386783A - Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf - Google Patents
Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf Download PDFInfo
- Publication number
- DK386783A DK386783A DK386783A DK386783A DK386783A DK 386783 A DK386783 A DK 386783A DK 386783 A DK386783 A DK 386783A DK 386783 A DK386783 A DK 386783A DK 386783 A DK386783 A DK 386783A
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- preparation
- acceptable salt
- pharmaceutical acceptable
- benzamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8224296 | 1982-08-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK386783D0 DK386783D0 (da) | 1983-08-23 |
| DK386783A true DK386783A (da) | 1984-02-25 |
Family
ID=10532494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK386783A DK386783A (da) | 1982-08-24 | 1983-08-23 | Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4507315A (fr) |
| JP (1) | JPS5955873A (fr) |
| KR (1) | KR840005717A (fr) |
| AT (1) | ATA301083A (fr) |
| AU (1) | AU1818083A (fr) |
| BE (1) | BE897580A (fr) |
| CA (1) | CA1195993A (fr) |
| CS (1) | CS240973B2 (fr) |
| DE (1) | DE3330403A1 (fr) |
| DK (1) | DK386783A (fr) |
| ES (2) | ES525099A0 (fr) |
| FI (1) | FI832989A (fr) |
| FR (1) | FR2532310B1 (fr) |
| GB (1) | GB2126225B (fr) |
| GR (1) | GR78673B (fr) |
| IL (1) | IL69544A0 (fr) |
| IT (1) | IT1169775B (fr) |
| LU (1) | LU84974A1 (fr) |
| NL (1) | NL8302947A (fr) |
| NO (1) | NO833024L (fr) |
| PT (1) | PT77219B (fr) |
| SE (1) | SE8304545L (fr) |
| ZA (1) | ZA836191B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0625144B2 (ja) * | 1986-02-24 | 1994-04-06 | 四国化成工業株式会社 | 新規イミダゾール化合物及び該化合物の合成方法 |
| US4916145A (en) * | 1987-07-10 | 1990-04-10 | Hoffmann-La Roche Inc. | Substituted n-[(pyridyl)alkyl]aryl-carboxamide |
| US4886629A (en) * | 1988-06-06 | 1989-12-12 | Allied-Signal Inc. | Process for the preparation of fluorinated benzene sulfonyl fluorides |
| CA2057324A1 (fr) * | 1990-12-18 | 1992-06-19 | Lora Louise Fitch | Agents hypoglycemiques de type benzamide et sulfonamide |
| US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| EP1196385A1 (fr) * | 1999-07-06 | 2002-04-17 | Vertex Pharmaceuticals Incorporated | Derives de beta-aminoacide destines au traitement de maladies neurologiques |
| DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| CN101061116A (zh) * | 2004-09-24 | 2007-10-24 | 詹森药业有限公司 | 磺酰胺化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3349124A (en) * | 1957-05-20 | 1967-10-24 | Pfizer & Co C | Oral antidiabetic agent |
| BE756062A (fr) * | 1969-09-11 | 1971-03-11 | Boehringer Sohn Ingelheim | Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides |
| DE2500157C2 (de) * | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung |
| DK148576A (da) * | 1975-04-18 | 1976-10-19 | Boehringer Mannheim Gmbh | Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling |
| DE2517229A1 (de) * | 1975-04-18 | 1976-10-28 | Boehringer Mannheim Gmbh | Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung |
| US4317915A (en) * | 1976-08-23 | 1982-03-02 | Hoffmann-La Roche Inc. | Novel thiophene derivatives |
| NZ186175A (en) * | 1977-01-27 | 1980-03-05 | Shionogi & Co | Meta-sulphonamidobenzamide derivatives |
| US4245120A (en) * | 1977-09-27 | 1981-01-13 | American Cyanamid Company | 4-(Monoalkylamino)benzene polycarboxylic acids |
| LU79008A1 (de) * | 1978-02-03 | 1979-09-06 | Byk Gulden Lomberg Chem Fab | W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel |
-
1983
- 1983-08-18 PT PT77219A patent/PT77219B/fr unknown
- 1983-08-22 CS CS836124A patent/CS240973B2/cs unknown
- 1983-08-22 SE SE8304545A patent/SE8304545L/xx not_active Application Discontinuation
- 1983-08-22 NO NO833024A patent/NO833024L/no unknown
- 1983-08-22 GB GB08322539A patent/GB2126225B/en not_active Expired
- 1983-08-22 KR KR1019830003923A patent/KR840005717A/ko not_active Application Discontinuation
- 1983-08-22 ZA ZA836191A patent/ZA836191B/xx unknown
- 1983-08-22 FI FI832989A patent/FI832989A/fi not_active Application Discontinuation
- 1983-08-22 US US06/525,503 patent/US4507315A/en not_active Expired - Fee Related
- 1983-08-22 GR GR72271A patent/GR78673B/el unknown
- 1983-08-22 IL IL69544A patent/IL69544A0/xx unknown
- 1983-08-22 JP JP58151746A patent/JPS5955873A/ja active Pending
- 1983-08-22 AU AU18180/83A patent/AU1818083A/en not_active Abandoned
- 1983-08-23 ES ES525099A patent/ES525099A0/es active Granted
- 1983-08-23 DE DE19833330403 patent/DE3330403A1/de not_active Withdrawn
- 1983-08-23 DK DK386783A patent/DK386783A/da unknown
- 1983-08-23 FR FR8313590A patent/FR2532310B1/fr not_active Expired
- 1983-08-23 LU LU84974A patent/LU84974A1/fr unknown
- 1983-08-23 AT AT833010A patent/ATA301083A/de not_active Application Discontinuation
- 1983-08-23 NL NL8302947A patent/NL8302947A/nl not_active Application Discontinuation
- 1983-08-23 BE BE0/211394A patent/BE897580A/fr not_active IP Right Cessation
- 1983-08-23 CA CA000435172A patent/CA1195993A/fr not_active Expired
- 1983-08-24 IT IT22629/83A patent/IT1169775B/it active
- 1983-12-13 ES ES528012A patent/ES8505935A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI832989A0 (fi) | 1983-08-22 |
| IL69544A0 (en) | 1983-11-30 |
| GB2126225B (en) | 1985-10-09 |
| FR2532310A1 (fr) | 1984-03-02 |
| ATA301083A (de) | 1985-11-15 |
| ES8502691A1 (es) | 1985-01-16 |
| ES528012A0 (es) | 1985-06-16 |
| BE897580A (fr) | 1984-02-23 |
| FI832989A (fi) | 1984-02-25 |
| ES525099A0 (es) | 1985-01-16 |
| IT1169775B (it) | 1987-06-03 |
| GB8322539D0 (en) | 1983-09-21 |
| NL8302947A (nl) | 1984-03-16 |
| NO833024L (no) | 1984-02-24 |
| JPS5955873A (ja) | 1984-03-31 |
| US4507315A (en) | 1985-03-26 |
| KR840005717A (ko) | 1984-11-16 |
| PT77219A (fr) | 1983-09-01 |
| CA1195993A (fr) | 1985-10-29 |
| ES8505935A1 (es) | 1985-06-16 |
| IT8322629A0 (it) | 1983-08-24 |
| GB2126225A (en) | 1984-03-21 |
| CS612483A2 (en) | 1985-06-13 |
| SE8304545D0 (sv) | 1983-08-22 |
| LU84974A1 (fr) | 1984-03-23 |
| FR2532310B1 (fr) | 1986-01-10 |
| DK386783D0 (da) | 1983-08-23 |
| GR78673B (fr) | 1984-09-27 |
| SE8304545L (sv) | 1984-02-25 |
| ZA836191B (en) | 1984-04-25 |
| AU1818083A (en) | 1984-03-01 |
| CS240973B2 (en) | 1986-03-13 |
| DE3330403A1 (de) | 1984-03-01 |
| PT77219B (fr) | 1986-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK74282A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK562081A (da) | Fremgangsmaade til fremsilling af et a-4696-p-seudo-aglycon eller et pharmaceutisk effektivt syreadditionssalt deraf | |
| ES526295A0 (es) | Un procedimiento para la preparacion de derivados de 1-normon-2-ilo | |
| DK166479C (da) | Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning | |
| DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DK373383D0 (da) | Fremgangsmade til fremstilling af omega-aminosyrederivater | |
| DK319884D0 (da) | Fremgangsmaader til fremstilling af 9a-ethyl- og 9a-n-propylderivater af 9-deoxo-9a-aza-9a-homoerythromycin a eller syreadditionssalte deraf | |
| DK335279A (da) | Fremgangsmaade til fremstilling af spirofuranohydantoin-forbindelser eller farmaceutisk acceptable metalsalte deraf | |
| DK53483A (da) | Fremgangsmaade til fremstilling af guanidinderivater | |
| DK386783A (da) | Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf | |
| DK85183A (da) | Fremgangsmaade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved | |
| DK162230C (da) | Fremgangsmaade til fremstilling af 2-thiacephemderivater | |
| DK149823C (da) | Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf | |
| DK553982A (da) | Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf | |
| ES538699A0 (es) | Un procedimiento para la preparacion de derivados de 1-normon-2-ilo | |
| ES537046A0 (es) | Un procedimiento para la preparacion de derivados de benzamida | |
| DK210183D0 (da) | Fremgangsmade til fremstillng af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK475783D0 (da) | Fremgangsmade til fremstilling af farmaceutiske praeparater | |
| DK226883A (da) | Fremgangsmaade til fremstilling af trialkylsiliciumholdige phenylcycloalkan-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK499983A (da) | Fremgangsmaade til fremstilling af 5-phenyl-hydantoin-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK91283D0 (da) | Fremgangsmade til fremstilling af erythromycin- eller oleandomycinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK163300C (da) | Analogifremgangsmaade til fremstilling af fluorerede alkandiaminderivater eller pharmaceutisk acceptable salte deraf | |
| DK346181A (da) | Fremgangsmaade til fremstilling af pyrazolobenzazepiner eller farmaceutisk acceptable salte deraf | |
| DK164283D0 (da) | Fremgangsmade til fremstilling af benzimidazolderivater | |
| DK497983D0 (da) | Fremgangsmade til fremstilling af 5-phenyl-hydantoin-derivater eller farmaceutisk acceptable salte deraf |